Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways.
about
What are the predictive factors in the risk and severity of chemotherapy-induced gastrointestinal toxicity?TLR4/PKC-mediated tight junction modulation: a clinical marker of chemotherapy-induced gut toxicity?Modeling pegylated liposomal doxorubicin-induced hand-foot syndrome and intestinal mucositis in zebrafish.Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice.Gut microbial colonization orchestrates TLR2 expression, signaling and epithelial proliferation in the small intestinal mucosaResuscitation strategies with different arterial pressure targets after surgical management of traumatic shock.The Adaptor Protein Myd88 Is a Key Signaling Molecule in the Pathogenesis of Irinotecan-Induced Intestinal MucositisIrinotecan-induced mucositis: the interactions and potential role of GLP-2 analogues.Depletion of enteric bacteria diminishes leukocyte infiltration following doxorubicin-induced small intestinal damage in miceIntestinal bacteria are necessary for doxorubicin-induced intestinal damage but not for doxorubicin-induced apoptosis.Sodium glucose cotransporter 1 ligand BLF501 as a novel tool for management of gastrointestinal mucositis.Chemotherapy-induced mucositis: the role of the gastrointestinal microbiome and toll-like receptors.The multifunctional alarmin HMGB1 with roles in the pathophysiology of sepsis and cancer.Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease.Immunogenic Apoptotic Cell Death and Anticancer Immunity.Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives.Sensing danger: toll-like receptors and outcome in allogeneic hematopoietic stem cell transplantation.Chemotherapeutic treatment reduces circulating levels of surfactant protein-D in children with acute lymphoblastic leukemia.Properdin deficiency protects from 5-fluorouracil-induced small intestinal mucositis in a complement activation-independent, interleukin-10-dependent mechanism.Shape induced acid responsive heat triggered highly facilitated drug release by cube shaped magnetite nanoparticles.Combination of Cinobufacini and Doxorubicin Increases Apoptosis of Hepatocellular Carcinoma Cells through the Fas- and Mitochondria-Mediated Pathways.Emu oil expedites small intestinal repair following 5-fluorouracil-induced mucositis in rats.Dietary Fiber Pectin Directly Blocks Toll-Like Receptor 2-1 and Prevents Doxorubicin-Induced Ileitis.Innate immunity in the small intestine
P2860
Q26798171-24A1B75D-3AFF-4B49-AE66-0C05659D3020Q27015742-909B1BD2-EEEB-4293-B56C-86C27619F9A4Q33857633-272ACDD3-60E1-4B3A-A2FD-E469245BEC77Q34342389-9C1A0DA0-D3A7-4663-A1C5-3072CF8D7B94Q34514746-BECEEA2B-7082-4901-A251-7F8BF67B9034Q35545242-AAF4973E-3F4E-4043-99A3-8B68512AE7A2Q36126947-895E6711-EAA2-4117-91C2-98E15C39C07DQ36171894-8950A6EF-798C-4DB7-BC6F-03E54A1E46B7Q36296826-4550B0BE-778D-484A-BF5F-E9F3DF7C2810Q37303696-6AAF02BA-D8F1-47F2-9D8B-941D9E9B157BQ37607488-4444E805-870F-4586-BA88-5B438F192640Q38088252-F408A8E7-DE32-4802-AF4B-D775A2BF95DDQ38116712-EE66B36E-AEBB-4BCE-AFBD-24E3F89EB9C8Q38681728-00DE1FFB-5BC6-45F8-BB4D-33902A42DB32Q38936705-3393D998-1941-4D0A-B5FB-C6AB28923B21Q38945299-5DF0862A-809F-4388-B3CE-06EC23DA0F55Q39035928-27929F70-E1A8-4EEF-BB0D-4000BD29D829Q39352647-A7359687-E739-4C58-A33F-5147CA525B2DQ40385731-94C32B49-CF0F-45E2-AAFB-7B35DDD2D8BCQ45956701-4E9D4CE7-E638-44C1-A44A-C0BF2B29C722Q47745678-6A60E1B9-C33F-4A31-8D2A-0592A5874E40Q51202695-E4323D3F-1177-42E5-8C0D-166BB3170221Q52653112-2D34475E-C9B8-4B42-88F6-AD70AAF16D2DQ57253397-F3782365-F574-4BC5-9C62-E0CA4E0E8744
P2860
Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Severity of doxorubicin-induce ...... the TLR-2 and TLR-9 pathways.
@ast
Severity of doxorubicin-induce ...... the TLR-2 and TLR-9 pathways.
@en
Severity of doxorubicin-induce ...... the TLR-2 and TLR-9 pathways.
@nl
type
label
Severity of doxorubicin-induce ...... the TLR-2 and TLR-9 pathways.
@ast
Severity of doxorubicin-induce ...... the TLR-2 and TLR-9 pathways.
@en
Severity of doxorubicin-induce ...... the TLR-2 and TLR-9 pathways.
@nl
prefLabel
Severity of doxorubicin-induce ...... the TLR-2 and TLR-9 pathways.
@ast
Severity of doxorubicin-induce ...... the TLR-2 and TLR-9 pathways.
@en
Severity of doxorubicin-induce ...... the TLR-2 and TLR-9 pathways.
@nl
P2093
P2860
P356
P1476
Severity of doxorubicin-induce ...... the TLR-2 and TLR-9 pathways.
@en
P2093
Agnieszka Kaczmarek
Brigitta M Brinkman
Liesbeth Heyndrickx
P2860
P304
P356
10.1002/PATH.3009
P577
2011-12-05T00:00:00Z